217 related articles for article (PubMed ID: 20731382)
1. Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA .
Karalewitz AP; Kroken AR; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
Biochemistry; 2010 Sep; 49(37):8117-26. PubMed ID: 20731382
[TBL] [Abstract][Full Text] [Related]
2. Unique ganglioside binding by botulinum neurotoxins C and D-SA.
Kroken AR; Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
FEBS J; 2011 Dec; 278(23):4486-96. PubMed ID: 21554541
[TBL] [Abstract][Full Text] [Related]
3. Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.
Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
J Biol Chem; 2012 Nov; 287(48):40806-16. PubMed ID: 23027864
[TBL] [Abstract][Full Text] [Related]
4. Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons.
Kroken AR; Karalewitz AP; Fu Z; Kim JJ; Barbieri JT
J Biol Chem; 2011 Jul; 286(30):26828-37. PubMed ID: 21632541
[TBL] [Abstract][Full Text] [Related]
5. Unique biological activity of botulinum D/C mosaic neurotoxin in murine species.
Nakamura K; Kohda T; Shibata Y; Tsukamoto K; Arimitsu H; Hayashi M; Mukamoto M; Sasakawa N; Kozaki S
Infect Immun; 2012 Aug; 80(8):2886-93. PubMed ID: 22665374
[TBL] [Abstract][Full Text] [Related]
6. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins.
Tsukamoto K; Kohda T; Mukamoto M; Takeuchi K; Ihara H; Saito M; Kozaki S
J Biol Chem; 2005 Oct; 280(42):35164-71. PubMed ID: 16115873
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC.
Zhang S; Berntsson RP; Tepp WH; Tao L; Johnson EA; Stenmark P; Dong M
Nat Commun; 2017 Nov; 8(1):1637. PubMed ID: 29158482
[TBL] [Abstract][Full Text] [Related]
8. Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.
Peng L; Berntsson RP; Tepp WH; Pitkin RM; Johnson EA; Stenmark P; Dong M
J Cell Sci; 2012 Jul; 125(Pt 13):3233-42. PubMed ID: 22454523
[TBL] [Abstract][Full Text] [Related]
9. Exchange of the H(CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin.
Rummel A; Mahrhold S; Bigalke H; Binz T
FEBS J; 2011 Dec; 278(23):4506-15. PubMed ID: 21624052
[TBL] [Abstract][Full Text] [Related]
10. Synaptotagmin Binding to Botulinum Neurotoxins.
Martínez-Carranza M; Blasco P; Gustafsson R; Dong M; Berntsson RP; Widmalm G; Stenmark P
Biochemistry; 2020 Feb; 59(4):491-498. PubMed ID: 31809018
[TBL] [Abstract][Full Text] [Related]
11. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
Peng L; Tepp WH; Johnson EA; Dong M
PLoS Pathog; 2011 Mar; 7(3):e1002008. PubMed ID: 21483489
[TBL] [Abstract][Full Text] [Related]
12. Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.
Davies JR; Liu SM; Acharya KR
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30347838
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding.
Stenmark P; Dong M; Dupuy J; Chapman ER; Stevens RC
J Mol Biol; 2010 Apr; 397(5):1287-97. PubMed ID: 20219474
[TBL] [Abstract][Full Text] [Related]
14. Preliminary X-ray crystallographic study of the receptor-binding domain of the D/C mosaic neurotoxin from Clostridium botulinum.
Nuemket N; Tanaka Y; Tsukamoto K; Tsuji T; Nakamura K; Kozaki S; Yao M; Tanaka I
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 May; 66(Pt 5):608-10. PubMed ID: 20445271
[TBL] [Abstract][Full Text] [Related]
15. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.
Strotmeier J; Lee K; Völker AK; Mahrhold S; Zong Y; Zeiser J; Zhou J; Pich A; Bigalke H; Binz T; Rummel A; Jin R
Biochem J; 2010 Oct; 431(2):207-16. PubMed ID: 20704566
[TBL] [Abstract][Full Text] [Related]
16. Unique ganglioside recognition strategies for clostridial neurotoxins.
Benson MA; Fu Z; Kim JJ; Baldwin MR
J Biol Chem; 2011 Sep; 286(39):34015-22. PubMed ID: 21849494
[TBL] [Abstract][Full Text] [Related]
17. P19 embryonal carcinoma cells exhibit high sensitivity to botulinum type C and D/C mosaic neurotoxins.
Tsukamoto K; Arimitsu H; Ochi S; Nakamura K; Tanaka Y; Nuemket N; Taniguchi K; Kozaki S; Tsuji T
Microbiol Immunol; 2012 Oct; 56(10):664-72. PubMed ID: 22738015
[TBL] [Abstract][Full Text] [Related]
18. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
[TBL] [Abstract][Full Text] [Related]
19. Subunit vaccine against the seven serotypes of botulism.
Baldwin MR; Tepp WH; Przedpelski A; Pier CL; Bradshaw M; Johnson EA; Barbieri JT
Infect Immun; 2008 Mar; 76(3):1314-8. PubMed ID: 18070903
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxin X lacks potency in mice and in human neurons.
Gregg BM; Matsumura T; Wentz TG; Tepp WH; Bradshaw M; Stenmark P; Johnson EA; Fujinaga Y; Pellett S
mBio; 2024 Mar; 15(3):e0310623. PubMed ID: 38347673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
